Cryoablation found highly effective for breast cancer patients with large tumors

by The Reis GroupMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA minimally invasive technique that uses ice to freeze and destroy small, cancerous tu

Oncology March 30,2024

Cryoablation found highly effective for breast cancer patients with large tumors

by The Reis GroupMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA minimally invasive technique that uses ice to freeze and destroy small, cancerous tu

Oncology March 30,2024

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Oncology March 30,2024

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Oncology March 30,2024

BRCA Exchange aggregates data on thousands of BRCA variants to understand cancer risk

by National Cancer InstituteCredit: National Cancer InstituteA global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes is available to the public. The B

Oncology March 30,2024

BRCA Exchange aggregates data on thousands of BRCA variants to understand cancer risk

by National Cancer InstituteCredit: National Cancer InstituteA global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes is available to the public. The B

Oncology March 30,2024

ASCO: ovarian suppression + tamoxifen ups breast CA survival

(HealthDay)—The addition of ovarian suppression to tamoxifen is associated with increased survival versus tamoxifen alone among premenopausal women with breast cancer, according to a study published o

Oncology March 30,2024

ASCO: ovarian suppression + tamoxifen ups breast CA survival

(HealthDay)—The addition of ovarian suppression to tamoxifen is associated with increased survival versus tamoxifen alone among premenopausal women with breast cancer, according to a study published o

Oncology March 30,2024

ASCO: guidelines released for early detection, treatment of CRC

(HealthDay)—Expert guidance has been provided on the early detection of colorectal cancer and on treatment and posttreatment follow-up; the two guidelines were recently published online in theJo

Oncology March 30,2024

ASCO: guidelines released for early detection, treatment of CRC

(HealthDay)—Expert guidance has been provided on the early detection of colorectal cancer and on treatment and posttreatment follow-up; the two guidelines were recently published online in theJo

Oncology March 30,2024

Bone cells suppress cancer metastases

by Thomas Jefferson UniversityCredit: CC0 Public DomainIn breast cancer, there are cases of women and men whose cancer returns in their bones 20-30 years after they were treated for their primary

Oncology March 30,2024

Bone cells suppress cancer metastases

by Thomas Jefferson UniversityCredit: CC0 Public DomainIn breast cancer, there are cases of women and men whose cancer returns in their bones 20-30 years after they were treated for their primary

Oncology March 30,2024

New drug targets for BRCA-driven cancer uncovered

by Brigham and Women's HospitalCredit: CC0 Public DomainBRCA1 and BRCA2 ("BReast CAncer genes") are critical tumor suppressor genes—women carrying a mutation in one of these genes h

Oncology March 30,2024

New drug targets for BRCA-driven cancer uncovered

by Brigham and Women's HospitalCredit: CC0 Public DomainBRCA1 and BRCA2 ("BReast CAncer genes") are critical tumor suppressor genes—women carrying a mutation in one of these genes h

Oncology March 30,2024

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat

Oncology March 30,2024

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat

Oncology March 30,2024

Advancing neuropathology with AI-driven classification of diffuse gliomas

by Liu Jia,Chinese Academy of SciencesTen examples of classification results on the external testing sets. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41195-9Diffuse

Oncology March 30,2024

Advancing neuropathology with AI-driven classification of diffuse gliomas

by Liu Jia,Chinese Academy of SciencesTen examples of classification results on the external testing sets. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41195-9Diffuse

Oncology March 30,2024

ASCO: liquid biopsy accurate for detecting colorectal cancer

(HealthDay)—Liquid biopsy that identifies circulating tumor cells in a blood sample has high accuracy for detecting colorectal cancer (CRC), according to a study presented at the American Society of C

Oncology March 30,2024

ASCO: liquid biopsy accurate for detecting colorectal cancer

(HealthDay)—Liquid biopsy that identifies circulating tumor cells in a blood sample has high accuracy for detecting colorectal cancer (CRC), according to a study presented at the American Society of C

Oncology March 30,2024